A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

VNTC confirms Dong-A ST its Sole Distributor of Scoliosis Brace Spinamic in South Korea

VNTC, a MedTech company, announced on June 15 its signing of a Korean distributorship contract with Dong-A ST. The two companies are now able to provide a wide range of services both at home and abroad through mutual cooperation in sales and marketing.

Vntc, Confirms Dong-A St Its Sole Distributor Of Scoliosis Brace Spinamic In South Korea
Spinamic, The World’s First Hybrid Scoliosis Brace Developed By Vntc

Dong-A ST, a subsidiary of Dong-A Socio Holdings, is a Korean pharmaceutical company with annual sales of KRW 600 billion. Recently, in addition to its main businesses, including prescription drug and domestic artificial joint supply, it is advancing into novel coronavirus infectious disease (COVID-19) detection kit market and AI-based medical imaging diagnostic business while expanding its medical device business through the scoliosis brace Spinamic. With this contract, VNTC also plans to focus on R&D of spine-related solutions to upgrade its product.

Spinamic is the world’s first hybrid scoliosis brace developed by VNTC. It merges the correction capability of conventional rigid plastic brace with the convenience of flexible fabric brace. Moreover, it has the advantage of being wearable for a wide range of patients, from those with mild scoliotic symptoms to those inconvenienced by the difficulty wearing plastic braces while receiving treatment, to physically challenged patients.

Similar to the rigid brace, the essential correction principles such as deflexion, derotation and elongation are implemented with various bands, pads, and pressure control devices. By simply tightening the dial on the device, the pressure intensity can be adjusted according to the improvement of a patient’s condition. It is also possible to customize as adolescents go through growth spurts. In terms of design, patients can find comfort in wearing the brace for the recommended 18 hours a day, thanks to its cleaner aesthetic and perfect fit.

Another benefit of Spinamic is that unlike other plastic braces that take more than two weeks to produce, Spinamic is customized immediately through X-ray data analysis and dimensional measurements and delivered to the patient on the same day.

Scoliosis is a disease in which the spine is bent sideways. About 4% of the world’s population suffers from this disease, and it is estimated that 44% of scoliosis patients are adolescents. As it develops into a mild, moderate or severe state according to the patient’s condition and requirement of surgery that may leave scars and side effects if left unattended, active treatment is key from the beginning.

The industry estimates the size of the related brace market to be KRW 4.7 trillion in the US, KRW 130 billion in Korea, KRW 710 billion in Japan and KRW 5.4 trillion in China.

“This exclusive distributor contract with Dong-A ST is the first large contract in the Korean scoliosis brace industry,” said a VNTC official. “Now we are able to actively expand the distribution network through our agents around the world and provide a broader brand exposure and in-depth service to scoliosis patients worldwide thanks to our superior product quality.” He also said, “VNTC plans to launch new products related to back and joint diseases subsequently our accomplishment in scoliosis brace technology.”

SourceVNTC
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy